New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds
ANN ARBOR, Mich. -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer…
Apr 25, 2011